HRSA Updates Cervical Cancer Screening Guidelines to Include Self-Collection
New guidelines designate high-risk HPV testing as preferred screening method for women ages 30-65 and require insurance coverage for additional testing.
Category: Cervical (HPV)
Cervical (HPV)
Latest
Cervical (HPV)
Latest
Seegene Unveils HPV Screening Solution
Seegene showcased its HPV screening and genotyping solutions, emphasizing the importance of accurate detection for cervical cancer.
Cervical (HPV)
Latest
Hologic Statement on USPSTF Draft Cervical Cancer Screening Guidelines
Hologic underscores the importance of combined Pap and HPV testing as the gold standard for cervical cancer screening.
Cervical Cancer Screening Could See Improved Accuracy
A new study has identified specific biomarkers in cervical mucus that could improve accuracy in the early detection of cervical cancer.
Read More
Seegene Showcases HPV Diagnostic Kits and PCR Technology
Seegene demonstrated its new HPV diagnostic products and emphasized the importance of HPV screening at the AOGIN conference.
Read More
Noninvasive Urine Test Could be Key in Cervical Cancer Detection
Researchers developed a urine test using ELISA to detect HPV16 E7 oncoproteins, a noninvasive method for cervical cancer screening.
Read More
HPV Self-Collection Is Recommended by Health Care Providers
A new study highlights support among healthcare providers for HPV self-collection, which could improve access to cervical cancer screening.
Read More
New Test Detects More Cases of Cervical Cancer
Researchers developed an effective cervical cancer screening method, which detects more cancers and precancerous stages than current methods.
Read More
U.S. Women Can Now Collect Their Own Cervical Cancer Screening Samples
BD received FDA approval for women to self-collect vaginal specimens for HPV testing, expanding access to cervical cancer screening.
Read More
Roche Announces FDA Approval of HPV Self-Collection Solution
che received FDA approval for its HPV self-collection solution, allowing individuals to collect their own samples.
Read More
At-Home Cervical Cancer Screening Device Gets FDA Breakthrough Designation
An at-home cervical cancer screening device received Breakthrough Device status to help increase testing access for people in need.
Read More
Researchers Discover Urine-Based Test to Detect Head and Neck Cancer
Researchers developed a urine-based test utilizing whole genome sequencing to detect DNA fragments released by head and neck tumors.
Read More
Rural-Urban Disparities in Cervical Cancer Screening
The research highlighted factors influencing cervical cancer screening and highlighted the need for interventions to increase screening.
Read More
CMS Designates HPV Blood Test as an Advanced Diagnostic Lab Test
The TTMV-HPV DNA blood test provides a non-invasive method for detecting HPV-driven cancers before there is clinical evidence of disease.
Read More
ASCCP Cervical Cancer Management Guidelines Support Dual-Stain Triage Testing
The ASCCP recognized dual-stain biomarkers as an important tech to determine if an HPV infection is transforming into cervical pre-cancer.
Read More
New Initiative Aims to Advance HPV-Driven Cancer Test
Naveris Launched an initiative aimed to expand the applications of its circulating Tumor Tissue Modified Viral (TTMV)-HPV DNA blood test.
Read More
BD and Camtech Health Partner to Improve Cervical Cancer Screening Access in Singapore
BD partnered with Camtech Health to advance cervical cancer screening by offering women in Singapore the option to self-collect a sample.
Read More
Cervical Cancer Screening: Survey Points to Self-Collection as Improving Access
In BD’s newest global survey, women reported self-collection would motivate them to have regular cervical cancer screening.
Read More